Pharma News
DCGI issues fresh code for drug inspectors to keep market vigil
The new code replaces a more-than-decade-old set of guidelines in view of changes in the procedure and advancements in the regulatory system.
3 min read15 Sep 2024Granules India shares plunge 16% after USFDA inspection ends with 6 observations
Granules India shares fell over 16% on September 12 after the USFDA inspection revealed six observations. The company reassured investors of its commitment to address the issues and uphold quality standards while promising timely updates.
1 min read12 Sep 2024Piramal Pharma share price jumps 23% in September so far and 68% YTD; investors could ’buy on dips’ says analyst
Piramal Pharma share price surged 23% in September and 68% YTD, driven by strong trading volumes and growth prospects. A minor correction occurred due to profit booking. The US Biosecure Act boosts confidence in Indian CDMO players, potentially increasing business opportunities.
2 min read12 Sep 2024Stock market today: Nifty 50 closes above 25,000, Sensex nears 82,000; IT stocks drive rally
Nifty 50 ended the session with a gain of 0.42 percent, closing above the 25,000 mark at 25,041 points. Similarly, the S&P BSE Sensex also closed higher, with a surge of 0.43 percent, reaching 81,912 points.
3 min read10 Sep 2024Top Stock Recommendations: Dharmesh Shah of ICICI Securities suggests buying Kajaria Ceramics, and Natco Pharma today
Top Stock Recommendations: Dharmesh Shah of ICICI Securities has recommended two stocks to buy this week - Kajaria Ceramics, and Natco Pharma.
4 min read9 Sep 2024CDMO stocks in focus as US House votes on Biosecure Act next week; Divi’s Lab, among others to benefit, says expert
The Biosecure Act may favour Indian CDMOs by limiting US partnerships with specific Chinese firms. Analysts predict a market surge driven by manufacturing cost advantages and increased demand for Indian contracts, marking a pivotal shift in the global CDMO landscape.
3 min read5 Sep 2024Freebies for doctors have gone on for too long. Now, the govt is clamping down
The Centre has sought expenditure details from these companies on distribution of free samples, and expenses incurred on organising conferences, workshops, training and seminars, as part of a broader initiative to curb unethical marketing practices by drugmakers.
3 min read5 Sep 2024Zydus Lifesciences stock slides 16% from recent peak, Elara Capital sees a buy opportunity; raises target price
Elara Capital sees Zydus Lifesciences’ stock correction as a buying opportunity, upgrading it to ’buy’ with a target of ₹1,497. Despite expected revenue declines in FY27, the company’s focus on specialty drugs and new products should offset these challenges, maintaining growth momentum.
3 min read3 Sep 2024US FDA’s surprise audit of plant briefly stalls the rise of this high-flying pharma stock
The Granules India stock came under selling pressure as the FDA continued a week-long surprise audit at one of the company’s key facilities.
4 min read3 Sep 2024Pharma stocks see 3rd straight month of gains in August, Mankind Pharma and 6 others rise up to 23%
Pharma stocks continued their bullish trend in August, with the Nifty Pharma index rising by 6.61%, driven by strong performances from Mankind Pharma and others. The index has gained 36% this year, benefiting from increased US sales, new product launches, and strong quarterly earnings.
3 min read2 Sep 2024Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared